Back to Search Start Over

hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

Authors :
Hancox, Jules C.
Melgari, Dario
Dempsey, Christopher E.
Brack, Kieran E.
Mitcheson, John
Ng, G. André
Source :
Therapeutic Advances in Drug Safety; August 2015, Vol. 6 Issue: 4 p177-179, 3p
Publication Year :
2015

Details

Language :
English
ISSN :
20420986 and 20420994
Volume :
6
Issue :
4
Database :
Supplemental Index
Journal :
Therapeutic Advances in Drug Safety
Publication Type :
Periodical
Accession number :
ejs37313862
Full Text :
https://doi.org/10.1177/2042098615595546